Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.60 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.53 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.53 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | ERN1 | O75460 | 2/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.47 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14015084 | 0.85 | ENPP2 (0.69) | ENPP2ORAI1ORAI2ORAI3ALDH1A1 | |
| SCHEMBL8004728 | 0.84 | KDM4E (0.70) | MAPTALDH1A1KDM4ETP53LMNA | |
| SCHEMBL31536724 | 0.83 | ALDH1A1 (0.61) | MAPTALDH1A1KDM4ETP53LMNA | |
| SCHEMBL7772568 | 0.83 | ENPP2 (0.65) | ENPP2ORAI1ORAI2ORAI3MAPT | |
| SCHEMBL1492289 | 0.83 | ENPP2 (0.65) | ENPP2ORAI1ORAI2ORAI3MAPT | |
| SCHEMBL30335989 | 0.77 | ALDH1A1 (0.58) | ENPP2MAPTALDH1A1KDM4ETP53 | |
| SCHEMBL7150727 | 0.77 | ALDH1A1 (0.58) | ENPP2MAPTALDH1A1KDM4ETP53 | |
| SCHEMBL23807 | 0.76 | ENPP2 (1.00) | ENPP2ORAI1ORAI2ORAI3MAPT | |
| SCHEMBL29466484 | 0.76 | ENPP2 (1.00) | ENPP2ORAI1ORAI2ORAI3MAPT | |
| Syringol SCHEMBL27708099 | 0.76 | KDM4E (0.70) | ENPP2ORAI1ORAI2ORAI3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4523747-A2 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | Suzhou Vincentage Pharma Co., Ltd (CN) | 2025-03-19 | — | — | EP | disclosed |
| EP-4212527-B1 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | SUZHOU VINCENTAGE PHARMA CO LTD (CN) | 2024-11-27 | — | — | EP | disclosed |
| US-11773087-B2 | GLP-1R receptor agonist compound and use thereof | SUZHOU VINCENTAGE PHARMA CO., LTD (CN) | 2023-10-03 | — | — | US | disclosed |
| US-20230257369-A1 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | Chengdu Vincentage Pharma Co., Ltd. (CN) | 2023-08-17 | — | — | US | disclosed |
| EP-4212527-A1 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | Suzhou Vincentage Pharma Co., Ltd (CN) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022116693-A1 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | 苏州闻泰医药科技有限公司 | 2022-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257369-A1 | GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF | GLP1R, GIPR, GPR119 | ENPP2 741/4885ORAI1 1392/4885ORAI2 1751/4885 |
| US-11773087-B2 | GLP-1R receptor agonist compound and use thereof | GLP1R, GIPR, GPR119 | ENPP2 741/4885ORAI1 1392/4885ORAI2 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.